Vaccine trial stopped after neurological symptoms detected
September 11, 2020
LONDON - A woman who received an experimental coronavirus vaccine developed severe neurological symptoms that prompted a pause in testing, a spokesman for drugmaker AstraZeneca said Thursday.
The study participant in late-stage testing reported symptoms consistent with transverse myelitis, a rare inflammation of the spinal cord, said company spokesman Matthew Kent.
"We don't know if it is (transverse myelitis)," Kent said. "More tests are being done now as part of the follow-up."